are a family of Rasrelated, low molecular mass (ϳ20 kDa), GTP-binding proteins that are expressed in all eukaryotes. There are six mammalian Arfs and many more Arf-like proteins. Like all GTPases, Arfs cycle between GDP-bound, inactive and GTP-bound, active states. In the active state, Arfs interact with proteins and other effector molecules to carry out their functions. Although Arf1 and its activities at the Golgi complex have been extensively studied, Arf6 has been the subject of increased attention over the past 5 years. Arf6 influences membrane trafficking and the actin cytoskeleton at the plasma membrane (PM). The goal of this review is to summarize these recent findings and provide a cellular context for understanding Arf6 function.
There are homologues of mammalian Arf6 in almost all eukaryotes including Xenopus laevis (97% amino acid sequence identity), Drosophila melanogaster (97%), Caenorhabditis elegans (88%), Schizosaccharomyces pombe (75%), and Saccharomyces cerevisiae (60%). All Arfs are N-terminally myristoylated, and all Arf6 homologues are basic proteins with predicted pIs in the range of 8.5-9.5. It is this characteristic and a signature dipeptide sequence (Gln-Ser) (1) adjacent to the effector domain interaction site, Switch I, that allow homologues of Arf6 to be identified. By contrast, other Arf isoforms have predicted pIs in the range of 6.0 -7.0. It is likely that its positive surface charge and N-terminal myristoylation target Arf6 to the plasma membrane. This may explain why, during the GTPase cycle, Arf6-GDP, unlike Arf1-GDP, is retained on membranes to a large extent (2, 3) although release of Arf6-GDP to the cytosol cannot be ruled out (4) . The absence of an Arf6 homologue in Arabadopsis or other plant species suggests that Arf6 is not present in plants.
Arf6 activation and inactivation are catalyzed by guanine nucleotide exchange factors (GEFs) that facilitate GTP binding and GTPase-activating proteins (GAPs) that catalyze GTP hydrolysis. In general, Arf6 GEFs are not inhibited by the fungal metabolite brefeldin A, in contrast with other Arf GEFs (5). The ARNO/cytohesin and EFA6 families of Arf6 GEFs contain a catalytic Sec7 homology domain and a pleckstrin homology domain thought to be involved in membrane targeting (5) . Arf-GEP100, another Arf6-specific GEF, also contains an IQ motif and localizes to endosomal membranes (6) . Candidate Arf6 GAPs are even more plentiful. These multidomain proteins can contain, in addition to the Arf GAP domain, pleckstrin homology, Src homology 2 and 3, and proline-rich domains capable of interacting with a multitude of signaling molecules that impact the actin cytoskeleton. As these regulators will not be further discussed, the reader is referred to two reviews in this area (5, 7) .
The molecular structures of both GDP-and GTP-bound Arf6 have been published, and the differences and similarities with the Arf1 structures provide some insight into mechanisms of activation and interaction with effector proteins (8) . The effector domain regions, Switch I and Switch II, are mostly identical in Arf6 and Arf1 and hence the two Arfs may share many interacting proteins. However, the glutamine and serine residues unique to Arf6 have been shown to confer distinct guanine nucleotide binding properties on Arf6 (9) and to be required for the actin rearrangement activities of Arf6 observed in cells (1) . Mutations of these two residues and others in the effector domain of Arf6 will be useful for sorting out Arf6-specific functions. For example, expression of Arf6 (T175A), a rapidly cycling Arf6 mutant (based on a similar mutation in Ras), caused increased PM ruffling and cell migration (10) . Additionally, Arf6 mutants defective in GTP binding (T27N) and GTP hydrolysis (Q67L) have been used to identify locations where active Arf6 is needed and to define the consequences of constitutively active Arf6, respectively. However, observations obtained with these inactive and active mutants should be interpreted with caution as Arf6 function normally depends on its GTPase cycle, and expression of any mutant that blocks the cycle may block Arf6 function (see below). By contrast, exogenous expression of wild type Arf6 has no discernible effect on cells in most cases (3) .
The many cellular functions ascribed to Arf6 indicate that the activities of Arf6 at the PM are complex. It is likely that Arf6 gets activated and inactivated at many locations along the PM where it can influence the sorting of membrane proteins, endocytic pathways, and the structure of the plasma membrane (Fig. 1) . This is reminiscent of Arf1 function at the Golgi complex where multiple sites of action of Arf1 influence many membrane trafficking steps into and out of the Golgi and the structure of the Golgi complex.
Arfs are thought to act through 1) the recruitment of cytosolic coat proteins onto membranes to facilitate sorting and vesicle formation, 2) the activation of lipid-modifying enzymes, and 3) the modulation of actin structures. The ability of active Arf1 to recruit a variety of cytosolic coat proteins onto Golgi membranes is well documented in vitro and in cells (11) . By contrast, there are as yet no identified coat proteins that are recruited to membranes by active Arf6, although the binding of Arf6-GTP to adaptor protein 1 and other cytosolic coat proteins has been demonstrated in vitro (12, 13) . Rather, Arf6 is more closely associated with membrane lipid modifications and modulation of the actin cytoskeleton (Fig. 2) .
Although all Arfs activate phosphatidylinositol 4-phosphate 5-kinase (PIP5-kinase) in vitro, in cells it is Arf6 that localizes with, and activates, PIP5-kinase (14) . PIP5-kinase is responsible for generating phosphatidylinositol 4,5-bisphosphate (PIP 2 ), a major PM phosphoinositide involved in membrane traffic and actin rearrangements (15, 16) . Therefore, this has provided a key to understanding cellular activities of Arf6. Furthermore, a biophysical study demonstrating that Arf6 binding to PIP 2 vesicles alters bilayer structure (17) suggests another way that Arf6 might affect membrane structure. Arfs also activate phospholipase D (PLD), an enzyme that hydrolyzes phosphatidylcholine to produce phosphatidic acid (PA), and in cells, PLD1 is activated by many agonists. Although the intracellular mediators in the pathway are not clear, accumulating evidence implicates Arf6, as it can directly bind to and activate PLD (18, 19) leading to regulated secretion (20) , stimulated membrane ruffling (21) , and other consequences associated with PLD activity (22) . Because PA can also activate PIP5-kinase, regulation of both PLD and PIP5-kinase by Arf6 can greatly amplify a PIP 2 -mediated signal (Fig. 2) . Thus, changes in membrane lipid composition and structure may mediate Arf6 alterations of the cortical actin cytoskeleton and regulation of membrane traffic and signal transduction.
Arf6 and Actin
The ability of Arf6 to affect the cortical actin cytoskeleton, cell shape, and cell migration is now well recognized (Fig. 1A) . In 1996, however, it was unexpected to find that an Arf protein could, upon activation, generate protrusive structures (23) . These observations were later extended to include a requirement for Arf6 activity for cell spreading (3), Rac-induced ruffling (24, 25) , cell migration (26 -28) , wound healing (27) , and Fc-mediated phagocytosis (29, 30) . The requirement was demonstrated by inhibition of these activities upon expression of the GTP-binding defective, dominant negative mutant of Arf6, T27N, and in some cases by the stimulation of these activities by overexpression of an Arf6 GEF (27, 31, 32) . It is important to note, however, that expression of Arf6Q67L, the constitutively active mutant, generally blocks all of the above actin activities (29, 32) , consistent with the requirement that Arf6 cycles between active and inactive forms to function properly.
In many cases it appears that Arf6 changes the actin structure at the PM through activation of Rac, the Rho protein implicated in membrane ruffling. Arf6 is required for and enhances the ability of Rac to form PM ruffles (24) . Furthermore, expression of an Arf6-specific GEF, EFA6, in cells generates protrusions and ruffles through activation of Arf6 (31, 32) and this activity appears to require Rac activation downstream of Arf6 activation (31) . Indeed, direct evidence that Arf6-GTP leads to activation of Rac has been obtained (27) , although the mechanism has not been identified. Interestingly, both Arf6 and Rac bind to a common effector protein Arfaptin 2/Partner of Rac (33) . Unfortunately, the function of Arfaptin 2 is not known, and it may show more specificity for Arf1 (34) . Another identified partner of Arf6, Arfophilin, appears to be more selective for Arf6 than for Arf1 (34) . This protein binds to Switch I and II regions of Arf6 but recognizes the N-terminal portion of Arf5 (34) . Intriguingly, Arfophilin is identical to a Rab11 effector protein, FIP3, suggesting common effectors that might bridge Arf6 and Rab11 functions (35) .
The effects of Arf6 on membrane lipid composition can also lead to changes in cortical actin cytoskeleton, perhaps working synergistically with activation of Rac. Phosphoinositides, and in particular, PIP 2 , can recruit and influence the activity of a number of actin-binding proteins that lead to changes in the cortical actin network (see Ref. 16 for review). PIP 2 , PIP5-kinase, and Arf6 are present together on the PM and endosomal membranes. Acute stimulation of Arf6 activation leads to protrusions of PIP 2 -rich PM driven by actin polymerization (14, 32) and stimulated membrane internalization and rapid recycling of the membrane back to the PM (32) (Fig. 1B) . At low expression levels, PIP5-kinase and Arf6 act synergistically to form protrusions (32) , and in CHO cells expression of either Arf6Q67L or PIP5-kinase generates actin comet-propelled endosomal membranes (36). 
Arf6 and Cell Polarity
Recent reports have implicated Arf6 in determining polarized structures in neuronal cells and in yeast and in the disassembly of polarized epithelium. Arf6 can regulate dendritic branching in hippocampal neurons (37) and neurite outgrowth in PC12 cells (38) . In yeast, the Arf6 homologue, Arf3, localizes to the growing bud and is important for polarized growth and bud site selection (39) .
The stimulation of migration of MDCK cells in response to growth factor (26, 40) or during wound healing (27) involves the transition from an epithelium with cells held together by adhesive interactions to more motile cells freed of these adhesions (Fig. 1C) . The transformation and conversion to a motile cell required the activation of Arf6, as these processes were inhibited by expression of Arf6T27N (26, 27) . In response to hepatocyte growth factor (HGF), Arf6 is continuously activated whereas Rac is initially inactivated, leading to the internalization of adherens junction proteins (40) . Active Arf6 binds to Nm23-H1, a nucleoside diphosphate kinase that has been implicated in both the inhibition of Rac activation and dynamindependent endocytosis, and could account for the observations at early times of HGF treatment (41) . At later times, levels of Rac-GTP increase and the cells begin to scatter (40) . Another study demonstrated that the activation of Arf6 induced by expression of ARNO, an Arf6 GEF, could initiate cell migration in the absence of HGF stimulation and enhance wound healing in MDCK cells (27) . The activation of Arf6 led to two downstream effects, one involving Rac activation and one involving PLD (27) . Although PLD activity was not required for the activation of Rac, both the Rac and PLD pathway were required for the stimulation of cell migration (27) . In addition to roles in stimulating migration of epithelial cells, Arf6 is also required in leukocytes for chemokine-stimulated migration across endothelial cells (28) .
Arf6 and Membrane Traffic
It is difficult to describe Arf6 actions on cell morphology, polarity, and the actin cytoskeleton without including its effects on membrane traffic. In addition to its PM localization, Arf6 is associated with endosomal membranes in many cells (42) . In kidney proximal tubules, Arf6 localizes to specialized apical endosomes (43) , and in CHO cells there is partial overlap between Arf6-associated endosomes and endosomes containing the transferrin receptor (44) . In HeLa and other types of epithelial cells, Arf6 is associated with a distinct endosomal compartment that contains integral membrane proteins that are endocytosed into cells independently of adaptor protein 2 and clathrin (45, 46) . This separate endosomal system that exists in parallel with the classical, transferrin-containing endosomal system is depicted in Fig. 1D and is the trafficking route followed by a number of PM proteins including the major histocompatibility complex class I proteins (MHCI) (45, 46) , integrins (32) , and E-cadherin (47) . After internalization, these proteins can either recycle back to the PM (45, 48) or fuse with the Rab5-associated endosomal system (46) . The crossover from the Arf6 endosome to the Rab5 endosome is apparently a trafficking route followed by the M2-muscarinic acetylcholine receptor (49) and may be part of the mechanism for the downregulation of surface MHCI induced by Nef, an HIV-encoded protein (50) . Nef stimulates the activation of Arf6, enhances endocytosis of MHCI, inhibits MHCI recycling, and causes MHCI to traffic to the Golgi complex, presumably from the Rab5 early endosome (50) .
Although Arf6 is associated with these endosomal membranes in HeLa cells, Arf6 activation is not required for internalization and trafficking through this pathway. Inactivation of Arf6, however, is a requirement. When Arf6 activation is stimulated and protrusions form, increased membrane is taken up by macropinocytosis and then recycled back to the PM, provided that Arf6 can be inactivated by GAP (32) . If, however, Arf6Q67L is overexpressed, membrane is internalized but not recycled, and cells accumulate PIP 2 and F-actin-coated endosomal structures (Fig. 1D ) that contain only clathrin-independent cargo proteins such as MHCI (32, 46) . Expression of the peripheral myelin protein, Pmp22, in HeLa cells appears to activate Arf6 and induces the formation of similar endocytic structures (51), suggesting a role for Arf6 in the formation of the myelin sheath, a process that is poorly understood.
Another membrane trafficking function attributed to Arf6 is its role in certain regulated secretory events (Fig. 1E) . In PC12 cells, Arf6 is associated with the dense core granules that are docked at the PM (52), and upon calcium stimulation, Arf6 is activated and increases PLD activity resulting in membrane fusion (20, 53) . Expression of a mutant of Arf6 (N48I) that cannot activate PLD inhibits secretion, demonstrating that activation of PLD is a major downstream effect of Arf6 that leads to secretion (53) . In another example, stimulation of adipocytes with endothelin acts via G␣ q to release a pool of Glut4-containing vesicles, but expression of Arf6T27N blocks this release (54, 55) . A recent study examining the role of Arf6 in Fc-mediated phagocytosis found that vesicles accumulated in cells expressing Arf6T27N, suggesting that activation of Arf6 leads to the exocytosis of vesicles required to complete phagocytosis (30) .
Arf6 at the PM: Priming and Sorting Functions
In addition to its effects on cortical actin and clathrin-independent endocytosis, Arf6 regulation of PIP 2 synthesis can influence other PM activities (Fig. 1F) . PIP 2 is required for the recruitment of AP2/clathrin onto forming clathrin-coated pits but is rapidly lost upon vesicle fission. A recent study demonstrated that Arf6Q67L binds to PIP5-kinase I-␥, activates the kinase, and leads to enhanced AP2/clathrin binding to a synaptic vesicle membrane preparation (56) . Interestingly, an earlier study reported an effect of expression of Arf6 mutants on the morphology of clathrin-coated pits at the apical surface of MDCK cells (57) .
Two areas of investigation have uncovered roles for Arf6 in sorting of PM proteins to facilitate their internalization. The agonist-induced down-regulation of ␤ 2 -adrenergic and luteinizing hormone receptors requires Arf6 activity. In both cases, engagement of the receptor leads to activation of Arf6 (58, 59) facilitating the release of sequestered arrestin to allow internalization via clathrin-mediated endocytosis (60) . Yet another role for Arf6 involves the transmembrane form of carboxypeptidase E (CPE), a sorting receptor for regulated secretory granules that, after secretion, is recycled back to the Golgi complex. This form of CPE extends about 6 amino acid residues (SETLNF) into the cytoplasm and interacts specifically with Arf6-GTP (61) . Remarkably, expression of Arf6-T27N blocks the recycling of CPE from the PM back to the Golgi, and mutation of the six residues in CPE important for Arf6 binding also inhibits recycling (61) .
Concluding Remarks
Although we are beginning to understand the breadth of Arf6 activities, the identification of more proteins that interact with Arf6 is needed to develop a molecular framework for understanding Arf6 function. The multiple sites of action of Arf6 at the PM highlight the importance of spatial and temporal regulation of Arf6 by connecting to specific GEFs, GAPs, and effectors. Although Arf6 may act in a constitutive capacity in resting cells, it is subject to acute stimulation through signal transduction pathways. Further studies on Arf6 function will shed light on the complex interplay between signal transduction, membrane traffic, and the cytoskeleton.
